The combination of biomarkers like NfL and GFAP, which have shown consistent results in clinical studies, strengthens the diagnostic potential of these models.18,47 A potential clinical use of a liquid biopsy multi-biomarker test may be in the initial cancer workup for localized tumor, which is typically done without CNS screening. The gene discussed is NEFL; the disease is cancer.